Type
ILEP Boletín Técnico 8: La Prevención de las Discapacidades Debidas a la Lepra. ILEP Boletín Técnico. Londres: Federación Internacional de Asociaciones contra la Lepra (ILEP); 1995.
Type
Akinola R, Mazandu G, Mulder N. A Quantitative Approach to Analyzing Genome Reductive Evolution Using Protein-Protein Interaction Networks: A Case Study of Mycobacterium leprae. Frontiers in genetics [Internet]. 2016;7:39. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809885/pdf/fgene-07-00039.pdf
Type
Camuset G, Lafarge S, Borgherini G, Gerber A, Pouderoux N, Foucher A, et al. Leprosy on Reunion Island, 2005-2013: Situation and Perspectives. PLoS neglected tropical diseases [Internet]. 2016;10(4):e0004612. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833340/pdf/pntd.0004612.pdf
Type
Hundeiker, Bassukas. [The Forthcoming History of Leprosy]. Pneumologie (Stuttgart, Germany). 2016;70(S 02):S174-S179.
Type
Cruz A. Leprosy as a multilayered biosocial phenomenon: The comparison of institutional responses and illness narratives of an endemic disease in Brazil and an imported disease in Portugal. Clinics in dermatology. 2016;34(1):16-23.
Type
Naafs B, Hees C. Leprosy type 1 reaction (formerly reversal reaction). Clinics in dermatology. 2016;34(1):37-50.
Type
Noordeen S. History of chemotherapy of leprosy. Clinics in dermatology. 2016;34(1):32-36.
Type
Schreuder P, Noto S, Richardus JH. Epidemiologic trends of leprosy for the 21st century. Clinics in dermatology. 2016;34(1):24-31.
Type
Grzybowski A, Nita M. Leprosy in the Bible. Clinics in dermatology. 2016;34(1):3-7.
Type
Zhang F, Liu H, Chen S, Low H, Sun L, Cui Y, et al. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nature genetics. 2011;43(12):1247-51.